Koyfin Home > Directory > Health Care > Amphastar Pharma > EV / EBITDA (ltm)

Amphastar Pharma EV / EBITDA (ltm) Chart (AMPH)

Amphastar Pharma annual/quarterly EV / EBITDA (ltm) from 2014 to 2018. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Amphastar Pharma EV / EBITDA (ltm) for the quarter ending March 03, 2018 was 71.27 a 57.04% increase of 40.65 year over year
  • Amphastar Pharma Annual EV / EBITDA (ltm) for 2017 was 96.65 a 82.79% increase of 80.01 from 2016
  • Amphastar Pharma Annual EV / EBITDA (ltm) for 2016 was 16.64 a -353.52% decrease of -58.81 from 2015
  • Amphastar Pharma Annual EV / EBITDA (ltm) for 2014 was 75.45
Other Valuation Metrics:
  • Amphastar Pharma Market Cap for the quarter ending March 03, 2018 was $869m a 6.01% increase of 52m year over year
  • Amphastar Pharma Price / Book for the quarter ending March 03, 2018 was 2.59 a 2.71% increase of 0.07 year over year
  • Amphastar Pharma Enterprise Value for the quarter ending March 03, 2018 was $848m a 8.52% increase of 72m year over year
View Chart On Koyfin

Quarterly AMPH EV / EBITDA (ltm) Data

03/201871.27
12/201796.65
09/201745.29
06/201730.62
03/201720.57
12/201616.64
09/201621.02
06/201637.45
03/201652.13
12/201475.45

Annual AMPH EV / EBITDA (ltm) Data

201796.65
201616.64
201475.45